Metraipolis › archive › dc_da18a965040d

Timing, fractionation, and dose of thoracic radiotherapy in patients with extensive-stage small cell lung cancer undergoing first-line Chemo-Immunotherapy — Europe PMC PMID:41704721

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704721
DOI
10.1016/j.ctro.2026.101114
License (as archived)
solo-consultazione
Archived
2026-11-06T02:28:47.366Z
SHA-256 of the archived text
ee996b1dd7659b890115728e4351cd5be3eb4c3720297aa6a46776043a6a19d7
Stable URL of this page
https://metraipolis.com/documento/dc_da18a965040d

How to cite

Timing, fractionation, and dose of thoracic radiotherapy in patients with extensive-stage small cell lung cancer undergoing first-line Chemo-Immunotherapy — Europe PMC PMID:41704721 — Europe PMC (en), https://europepmc.org/article/MED/41704721 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da18a965040d (Metraipolis archive dc_da18a965040d, sha256 ee996b1dd7659b890115728e4351cd5be3eb4c3720297aa6a46776043a6a19d7)
BibTeX
@misc{dcda18a965040d,
  title = {Timing, fractionation, and dose of thoracic radiotherapy in patients with extensive-stage small cell lung cancer undergoing first-line Chemo-Immunotherapy — Europe PMC PMID:41704721},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704721},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da18a965040d; sha256 ee996b1dd7659b890115728e4351cd5be3eb4c3720297aa6a46776043a6a19d7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704721. Agents can read the archived copy with the MCP tool read_document.